We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
-16.2%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$252M
AUM Growth
-$37.6M
Cap. Flow
+$15.8M
Cap. Flow %
6.27%
Top 10 Hldgs %
66.85%
Holding
65
New
5
Increased
12
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$7.57M
2
AMZN icon
Amazon
AMZN
+$5.52M
3
META icon
Meta Platforms (Facebook)
META
+$4.94M
4
LNG icon
Cheniere Energy
LNG
+$3.23M
5
MOS icon
The Mosaic Company
MOS
+$2.82M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$5.49M
2
RBLX icon
Roblox
RBLX
+$2.61M
3
RGNX icon
Regenxbio
RGNX
+$1.25M
4
CFLT
Confluent
CFLT
+$1.24M
5
XES icon
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
+$829K

Sector Composition

Rank Sector Weight
1 Communication Services 32.04%
2 Consumer Discretionary 17.15%
3 Healthcare 16.9%
4 Energy 11.75%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOP icon
51
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.53B
$239K 0.09%
2,000
– –
AGNC icon
52
AGNC Investment
AGNC
$12.6B
$123K 0.05%
11,010
– –
NLY icon
53
Annaly Capital Management
NLY
$17B
$103K 0.04%
4,188
– –
LABP
54
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$93K 0.04%
12,726
-149
-1% -$1.35K
DM
55
DELISTED
Desktop Metal, Inc.
DM
$90K 0.04%
4,070
– –
ATXS
56
DELISTED
Astria Therapeutics
ATXS
$77K 0.03%
25,747
– –
VBIV
57
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$53K 0.02%
2,167
– –
ZY
58
DELISTED
Zymergen Inc. Common Stock
ZY
$42K 0.02%
34,000
+13,000
+62% +$21.8K
CFLT
59
DELISTED
Confluent
CFLT
– –
-30,184
Closed -$1.24M
GREK
60
Global X MSCI Greece ETF
GREK
$315M
– –
-19,829
Closed -$527K
HOOD icon
61
Robinhood
HOOD
$81.9B
– –
-406,500
Closed -$5.49M
NIU
62
Niu Technologies
NIU
$191M
– –
-40,644
Closed -$393K
RBLX icon
63
Roblox
RBLX
$26.4B
– –
-56,465
Closed -$2.61M
SJNK icon
64
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.75B
– –
-8,028
Closed -$211K
V icon
65
Visa
V
$686B
– –
-1,000
Closed -$222K
1 2
3

Similar funds

CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
CWAF
Core Wealth Advisors (Florida) Lakeland, Florida $419M AUM 16.86% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return
PIMC
Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return

ArchPoint Investors's Q2 2022 Portfolio in Review

As of Q2 2022, ArchPoint Investors held 65 positions worth $252M, down 13% from $290M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

ArchPoint Investors deployed $15.8M of net new capital in Q2 2022, opening 5 new positions and adding to 12 existing holdings. Its largest new stake was Meta Platforms (Facebook): 25,600 shares worth $4.13M.

By sector, the portfolio is most concentrated in Communication Services at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Regenxbio, an estimated $1.25M trimmed.

  • ArchPoint Investors's largest Q2 2022 buy was Meta Platforms (Facebook): 25,600 shares worth $4.13M.
  • ArchPoint Investors added most to Alphabet (Google) Class A in Q2 2022, an estimated $7.57M increase.
  • ArchPoint Investors's biggest Q2 2022 reduction was Regenxbio, cutting an estimated $1.25M.
  • ArchPoint Investors fully exited Robinhood in Q2 2022, selling an estimated $5.49M.
  • ArchPoint Investors's ten largest holdings make up 67% of its $252M portfolio in Q2 2022.
  • ArchPoint Investors opened 5 new positions and closed 7 in Q2 2022.
  • ArchPoint Investors's portfolio value fell 13% quarter-over-quarter to $252M.

Based on ArchPoint Investors's 13F filing for Q2 2022, filed 12 Aug 2022.